GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » 5-Year Yield-on-Cost %

Invictus MD Strategies (Invictus MD Strategies) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies 5-Year Yield-on-Cost %?

Invictus MD Strategies's yield on cost for the quarter that ended in Oct. 2019 was 0.00.


The historical rank and industry rank for Invictus MD Strategies's 5-Year Yield-on-Cost % or its related term are showing as below:



IVITF's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.22
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Invictus MD Strategies's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's 5-Year Yield-on-Cost % falls into.



Invictus MD Strategies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Invictus MD Strategies is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Invictus MD Strategies  (OTCPK:IVITF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Invictus MD Strategies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS ANNOUNCES RESIGNATIONS

By Marketwired Marketwired 12-06-2019

Invictus announces Annual General Meeting Results

By Marketwired Marketwired 07-25-2019

INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING

By Marketwired Marketwired 12-16-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

By Marketwired Marketwired 06-26-2019

INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

By Marketwired Marketwired 06-28-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By Marketwired Marketwired 12-14-2019